Show simple item record

dc.contributor.authorPetersen, Kamilla Vandsø
dc.contributor.authorSelas Lanseros, Asier
dc.contributor.authorHymøller, Kirstine Mejlstrup
dc.contributor.authorMizielinski, Karol
dc.contributor.authorThorsager, Maria
dc.contributor.authorStougaard, Magnus
dc.contributor.authorAlonso Pérez, Concepción Estibaliz ORCID
dc.contributor.authorPalacios Gambra, Francisco Javier ORCID
dc.contributor.authorPérez-Pertejo, Yolanda
dc.contributor.authorReguera, Rosa M.
dc.contributor.authorBalaña-Fouce, Rafael
dc.contributor.authorKnudsen, Birgitta Ruth
dc.contributor.authorTesauro, Cinzia
dc.date.accessioned2021-09-13T11:27:50Z
dc.date.available2021-09-13T11:27:50Z
dc.date.issued2021-08-13
dc.identifier.citationPharmaceutics 13(8) : (2021) // Article ID 1255es_ES
dc.identifier.issn1999-4923
dc.identifier.urihttp://hdl.handle.net/10810/53077
dc.description.abstractBackground: Eukaryotic topoisomerase 1 is a potential target of anti-parasitic and anti-cancer drugs. Parasites require topoisomerase 1 activity for survival and, consequently, compounds that inhibit topoisomerase 1 activity may be of interest. All effective topoisomerase 1 drugs with anti-cancer activity act by inhibiting the ligation reaction of the enzyme. Screening for topoisomerase 1 targeting drugs, therefore, should involve the possibility of dissecting which step of topoisomerase 1 activity is affected. Methods: Here we present a novel DNA-based assay that allows for screening of the effect of small-molecule compounds targeting the binding/cleavage or the ligation steps of topoisomerase 1 catalysis. This novel assay is based on the detection of a rolling circle amplification product generated from a DNA circle resulting from topoisomerase 1 activity. Results: We show that the binding/cleavage and ligation reactions of topoisomerase 1 can be investigated separately in the presented assay termed REEAD (C|L) and demonstrate that the assay can be used to investigate, which of the individual steps of topoisomerase 1 catalysis are affected by small-molecule compounds. The assay is gel-free and the results can be detected by a simple colorimetric readout method using silver-on-gold precipitation rendering large equipment unnecessary. Conclusion: REEAD (C|L) allows for easy and quantitative investigations of topoisomerase 1 targeting compounds and can be performed in non-specialized laboratories.es_ES
dc.description.sponsorshipK.V. thanks Aase and Ejnar Danielsens Fond, Aage and Johanne Louis-Hansens Fond and Edel and Wilhelm Daubenmerkls Almenvelgørende Fond; A.S. thanks the Basque Government for a formation contract.es_ES
dc.language.isoenges_ES
dc.publisherMDPIes_ES
dc.rightsinfo:eu-repo/semantics/openAccesses_ES
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es/
dc.subjecttopoisomerase 1es_ES
dc.subjectREEADes_ES
dc.subjectrolling circle amplificationes_ES
dc.subjectsmall-molecule compoundses_ES
dc.subjectdrug screeninges_ES
dc.subjectenzyme activityes_ES
dc.subjectcolorimetric readoutes_ES
dc.titleSimple and Fast DNA Based Sensor System for Screening of Small-Molecule Compounds Targeting Eukaryotic Topoisomerase 1es_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.date.updated2021-09-09T13:45:05Z
dc.rights.holder2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).es_ES
dc.relation.publisherversionhttps://www.mdpi.com/1999-4923/13/8/1255/htmes_ES
dc.identifier.doi10.3390/pharmaceutics13081255
dc.departamentoesQuímica orgánica I
dc.departamentoeuKimika organikoa I


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Except where otherwise noted, this item's license is described as 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).